| pubmed-article:9783100 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9783100 | lifeskim:mentions | umls-concept:C0030956 | lld:lifeskim |
| pubmed-article:9783100 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:9783100 | lifeskim:mentions | umls-concept:C1527392 | lld:lifeskim |
| pubmed-article:9783100 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:9783100 | pubmed:dateCreated | 1998-11-25 | lld:pubmed |
| pubmed-article:9783100 | pubmed:abstractText | Four-day monitoring using standard methods of studying free group behavior of animals in an "open field" (Opto-Varimex, USA) showed that all the peptide immunomodulators under study possessed a neuromodulating effect comparable with that of known drugs. They change the character of the circadian rhythms of the animals' motor activity and the dynamics of extinction of the orientation-investigation reaction. In comparison with the control the activity of the drugs under study was distributed as follows: ethymizol > cerebrolysin > thymalin > nootropil > thymogen > T-activin > cortexin > dibazol. | lld:pubmed |
| pubmed-article:9783100 | pubmed:language | rus | lld:pubmed |
| pubmed-article:9783100 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9783100 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9783100 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9783100 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9783100 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9783100 | pubmed:issn | 0869-2092 | lld:pubmed |
| pubmed-article:9783100 | pubmed:author | pubmed-author:GrechkoA TAT | lld:pubmed |
| pubmed-article:9783100 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9783100 | pubmed:volume | 61 | lld:pubmed |
| pubmed-article:9783100 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9783100 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9783100 | pubmed:pagination | 14-6 | lld:pubmed |
| pubmed-article:9783100 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9783100 | pubmed:meshHeading | pubmed-meshheading:9783100-... | lld:pubmed |
| pubmed-article:9783100 | pubmed:meshHeading | pubmed-meshheading:9783100-... | lld:pubmed |
| pubmed-article:9783100 | pubmed:meshHeading | pubmed-meshheading:9783100-... | lld:pubmed |
| pubmed-article:9783100 | pubmed:meshHeading | pubmed-meshheading:9783100-... | lld:pubmed |
| pubmed-article:9783100 | pubmed:meshHeading | pubmed-meshheading:9783100-... | lld:pubmed |
| pubmed-article:9783100 | pubmed:meshHeading | pubmed-meshheading:9783100-... | lld:pubmed |
| pubmed-article:9783100 | pubmed:meshHeading | pubmed-meshheading:9783100-... | lld:pubmed |
| pubmed-article:9783100 | pubmed:meshHeading | pubmed-meshheading:9783100-... | lld:pubmed |
| pubmed-article:9783100 | pubmed:meshHeading | pubmed-meshheading:9783100-... | lld:pubmed |
| pubmed-article:9783100 | pubmed:articleTitle | [The neurotropic activity of peptide immunomodulators]. | lld:pubmed |
| pubmed-article:9783100 | pubmed:affiliation | Military Medical Academy, St. Petersburg, Russia. | lld:pubmed |
| pubmed-article:9783100 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9783100 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:9783100 | pubmed:publicationType | English Abstract | lld:pubmed |
